DHCR24 Antibodies

Santa Cruz Biotechnology features a diverse variety of DHCR24 monoclonal antibodies for research focused on understanding DHCR24 protein function. DHCR24 Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DHCR24, also known as 24-dehydrocholesterol reductase, is an essential enzyme involved in cholesterol biosynthesis and plays a significant role in maintaining cellular cholesterol homeostasis. Dysregulation of DHCR24 has been implicated in various diseases, including neurodegenerative disorders and cancer, highlighting its importance in both health and disease. Understanding the function and regulation of DHCR24 can provide valuable insights into therapeutic targets and disease mechanisms. Researchers worldwide rely on DHCR24 monoclonal antibodies to advance their studies in cholesterol metabolism and related pathways. DHCR24 monoclonal antibodies enable reproducible experimental results. Multiple formats are available to accommodate diverse experimental needs and protocols. Santa Cruz Biotechnology monoclonal antibodies for DHCR24 continue to support breakthrough discoveries in biomedical research and therapeutic development.